Page last updated: 2024-08-23

lovastatin and Lymph Node Metastasis

lovastatin has been researched along with Lymph Node Metastasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eder, IE; Egger, M; Klocker, H; Plattner, R; Yang, L	1

Other Studies

1 other study(ies) available for lovastatin and Lymph Node Metastasis

Article	Year
Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells. Urology, 2011, Volume: 77, Issue:6 Topics: Androgens; Caspase 3; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoassay; Lovastatin; Lymphatic Metastasis; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, Androgen; RNA, Small Interfering; Signal Transduction	2011

Article

Year

Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells.

Urology, 2011, Volume: 77, Issue:6

Topics: Androgens; Caspase 3; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoassay; Lovastatin; Lymphatic Metastasis; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, Androgen; RNA, Small Interfering; Signal Transduction

2011